Wu et al. suggested that isocitrate dehydrogenase 1 mutations (mIDH1) promotes TET2 dependent induction of interferon γ (IFN-γ)-responsive genes in tumor cells by inhibiting the recruitment of stimulated CD8+ T cells and the expression of IFN-γ. The gene discussed is IFNG; the disease is neoplasm.